Safety and efficacy of Favipiravir in moderate to severe SARS-CoV-2 pneumonia-Reference-Cited by-同舟云学术

Safety and efficacy of Favipiravir in moderate to severe SARS-CoV-2 pneumonia

Published:2021-06 Issue: Volume:95 Page:107522
ISSN:1567-5769
Container-title:International Immunopharmacology
language:en
Short-container-title:International Immunopharmacology

Author:

Solaymani-Dodaran Masoud,Ghanei Mostafa,Bagheri Mehdi,Qazvini Ali,Vahedi Ensieh,Hassan Saadat Seyed,Amin Setarehdan Seyed,Ansarifar Akram,Biganeh Hossein,Mohazzab Arash,Khalili Davood,Hosein Ghazale Amir,Reza Heidari Mohammad,Taheri Ali,Khoramdad Maliheh,Mahdi Asadi Mohammad,Nazemieh Masoud,Varshochi Mojtaba,Abbasian Samaneh,Bakhtiari Ali,Mosaed Reza,Hosseini-shokouh Seyyed-Javad,Shahrokhi Masoume,Yassin Zeynab,Ali Zohal Mohammad,Qaraati Maryam,Rastgoo Nafiseh,Sami Ramin,Javad Eslami Mohammad,Asghari Akram,Namazi Mansoor,Ziaie Shadi,Jafari-Moghaddam Raana,Kalantari Saeid,Memarian Mohammad,Khodadadi Javad,Hossein Afshari Mohammad,Momen-Heravi Mansooreh,Behzadseresht Niusha,Reza Mobayen Ahmad,Mozafari Abolfazl,Movasaghi Fatemeh,Haddadzadeh Shoushtari Maryam,Moazen Javad

Funder

Baqiyatallah University of Medical Sciences

Iran University of Medical Sciences

Publisher

Elsevier BV

Subject

Pharmacology,Immunology,Immunology and Allergy

Reference31 articles.

1. Literature-based review of the drugs used for the treatment of COVID-19;Venkatasubbaiah;Curr Med Res Pract,2020

2. Antiviral treatment of COVID-19. Turk;Şimşek Yavuz;J Med Sci,2020

3. The Impact of the COVID-19 “Infodemic” on Drug-Utilization Behaviors: Implications for Pharmacovigilance;Tuccori;Drug Safety,2020

4. In Vitro and In Vivo Activities of Anti-Influenza Virus Compound T-705;Furuta;Antimicrobial Agents and Chemotherapy,2002

5. Favipiravir (T-705), a broad spectrum inhibitor of viral RNA polymerase;Furuta;Proceedings of the Japan Academy Series B, Physical and biological sciences,2017

Cited by 56 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical Course and Factors Associated With Hospital Admission and Mortality among Sars-Cov 2 Patients within Nairobi Metropolitan Area;2024-05-15

2. Evaluation of the relationship of treatment and vaccination with prognosis in patients with a diagnosis of COVID-19;Inflammopharmacology;2024-03-16

3. Favipiravir for treating COVID-19;Cochrane Database of Systematic Reviews;2024-02-05

4. Clinical antiviral efficacy of favipiravir in early COVID-19 (PLATCOV): an open-label, randomised, controlled, adaptive platform trial;BMC Infectious Diseases;2024-01-15

5. Clinical Outcomes of COVID-19 Disease in Young and Middle Aged Adults;Bulletin of Cardiovasculer Academy;2023-10-20